期刊文献+

慢性心力衰竭的规范治疗效果分析 被引量:1

Effect of Standard Treatment on Chronic Heart Failure
下载PDF
导出
摘要 目的分析慢性心力衰竭(慢性心衰)患者规范治疗的临床效果。方法选择2008年1月—2012年6月入住我院的慢性心衰患者176例,对患者的相关资料进行分析,记录其治疗方法、治疗结果、不良反应、随访1年后病情及明尼苏达心衰生活质量评分(LiHFe)。结果患者总有效率为100.0%;未出现严重药物不良反应;出院后1年发生心脑血管事件患者经过积极治疗均得到有效控制;规范治疗前LiHFe得分高于随访1年后(P<0.05)。结论规范慢性心衰患者的治疗,能提高临床效果及患者生活质量。 Objective To analyze the clinical effect of standard treatment on chronic heart failure. Methods 176 cases of patients with heart failure were chosen from January 2008 to June 2012, and related information was collected, the pa- tient's underlying data were analyzed. Its treatment, treatment outcomes, adverse reactions, after 1 year the condition and qual- ity of life scores of Minnesota Heart Failure (LiHFe) were recorded. Results The total effective rate was 100.0% ; No serious adverse drug reactions oeeured ; 1 year after discharge patients with cardiovascular and eerebrovascular events had been effectively controlled after active treatment; LiHFe before standard treatment scored higher than after 1 year (P 〈0. 05 ). Conclusion Standardize the treatment of patients with chronic heart failure, can significantly enhance clinical effect and the patients's quality of life.
作者 罗卉
出处 《实用心脑肺血管病杂志》 2013年第11期66-67,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 心力衰竭 规范治疗 治疗结果 Heart failure Standard treatment Treatment outcome
  • 相关文献

参考文献10

二级参考文献126

  • 1王兰兰,蔡蓓,刘兴斌,刘瑾,黄德嘉,唐江涛,李立新.N末端脑型钠尿肽定量检测在心力衰竭诊断中的价值[J].中华检验医学杂志,2006,29(1):35-38. 被引量:50
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 3曹雅旻,胡大一,王宏宇,吴彦.我国基层医院慢性心力衰竭药物治疗现状调查[J].中华内科杂志,2006,45(11):907-909. 被引量:72
  • 4Friedrich M,Fruhwald R,Peter R,et al.Austrian survey of treating heart failure-AUSTRIA[J].Eur J Heart Failure,2004,6(7):1-7.
  • 5Douglas PZ,Micheal R,Brain D,et al.Managment of heart failure[J].Braunwald Heart Disease,2004,7:603-617.
  • 6Akosah KO,Schaper AM,Havlik P,et al.Improving care for patients with chronic heart failure in the community:the importance of a dise ase managment program[J].Chest,2002,123(5):906-912.
  • 7While A,Kiek F.Chronic heart failure:promoting quality of life[J].Br J Community Nurs,2009,14(2):54-59.
  • 8邵春来 洪小苏 朱雪民 等.血浆BNP联合LVEF对心力衰竭患者预后的评估价值.全国心血管病实验室诊断与临床专题学术研讨会,2007,:100-101.
  • 9Gty C, Mey A, Puleat M. Finetuning in Ca2 + homeostasis underlies progyession of eardiomyopathy in myocytes derived from genetically, modified embryonic stem cells [J].Hum Mol Cenet, 2005, 14 (10) : 1369.
  • 10Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left - ventricular systolic function intolerant to angiotensin- converting enzyme inhibitors: The Charra-altemativeTrial [J]. Lancet, 2003, 362: 772-776.

共引文献3975

同被引文献9

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部